Flynn Zito Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Flynn Zito Capital Management's PFE Position: Q1 2026 in Review
Flynn Zito Capital Management increased its Pfizer (PFE) stake by 2.3% in Q1 2026, buying an estimated $5.83K and bringing the position to 9,675 shares worth $272K. The position accounts for 0.09% of the portfolio, ranked #114.
Flynn Zito Capital Management first reported a position in PFE in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.16M in Q4 2021. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Flynn Zito Capital Management held 9,675 shares of Pfizer worth $272K as of Q1 2026.
- Flynn Zito Capital Management bought 219 Pfizer shares in Q1 2026, an estimated $5.83K.
- Pfizer made up 0.09% of Flynn Zito Capital Management's portfolio in Q1 2026, its #114 holding.
- Flynn Zito Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 14 quarters since.
- Flynn Zito Capital Management's Pfizer position peaked at $1.16M in Q4 2021.
- 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Flynn Zito Capital Management's 13F filing for Q1 2026, filed 4 May 2026.